Effect on Metabolic Parameters of Abilify in SPR

Metabolic Signatures and Biomarkers in Schizophrenia

NCT00466310 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Aripiprazole in First Episode Psychosis

NCT01026584 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia

NCT00202007 ·Status: COMPLETED ·Phase: PHASE2

The New Strategy for Pharmacological Treatment in People With Schizophrenia

NCT00352339 ·Status: UNKNOWN ·Phase: PHASE4

Aripiprazole Once-monthly in Patients With Schizophrenia

NCT01959035 ·Status: COMPLETED ·Phase: PHASE3

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

NCT01432444 ·Status: COMPLETED ·Phase: PHASE3

Effect on Cognitive Function of a Treatment With Aripiprazole

NCT00329810 ·Status: COMPLETED ·Phase: PHASE4

A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

NCT00292409 ·Status: COMPLETED ·Phase: PHASE3

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

NCT00392197 ·Status: COMPLETED ·Phase: PHASE4

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

NCT00541554 ·Status: UNKNOWN ·Phase: PHASE4

Broad Effectiveness: Study With Aripiprazole

NCT00036361 ·Status: COMPLETED ·Phase: PHASE3

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

NCT00328367 ·Status: COMPLETED ·Phase: PHASE4

Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

NCT03150771 ·Status: COMPLETED ·Phase: PHASE1

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

NCT00325689 ·Status: COMPLETED ·Phase: PHASE4

A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices

NCT00237939 ·Status: COMPLETED ·Phase: PHASE3

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

NCT03130465 ·Status: UNKNOWN

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

NCT03005769 ·Status: COMPLETED

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

NCT01509053 ·Status: TERMINATED ·Phase: PHASE3

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

NCT01870999 ·Status: COMPLETED ·Phase: PHASE1

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

NCT01683058 ·Status: COMPLETED ·Phase: PHASE3

Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia

NCT01795547 ·Status: COMPLETED ·Phase: PHASE3

SWitching to Abilify Trial (SWAT)

NCT00304616 ·Status: COMPLETED ·Phase: PHASE4

A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

NCT06589817 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

NCT00036114 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

NCT00545467 ·Status: COMPLETED ·Phase: PHASE4